A multicentre, randomized, single‐blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once‐daily gel versus clindamycin 1% twice‐daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients

Jinhua Xu(Shanxi Medical University), AG Hamedani(GlaxoSmithKline (United States)), Y. Tu(Union Hospital), Jinhua Huang(Central South University), Qianjin Lu(Central South University), Weixin Sheng(Wuhan University), M. Li(Fudan University), Jun Gu(Peking University), Hong Fang(Arkansas State University), Qiuning Sun(Anhui Medical University), Liyan Xi(Sun Yat-sen University), Gang Wang(Wuhan University), Dan Luo(Cornell University), Min Zheng(Second Affiliated Hospital of Zhejiang University), Heng Gu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie Zheng(Tangshan People's Hospital), Fei Hao(Suzhou Institute of Nano-tech and Nano-bionics), Yan He(Kunming Medical University), Hongqing Tian(Shandong Provincial Hospital), Huilan Yang(General Hospital of Guangzhou Military Command), J D Li(GlaxoSmithKline (China)), Guixin Zhao(Air Force General Hospital PLA), Xiuqin Dong(Guangdong Academy of Medical Sciences), F.Q. Li(Second Affiliated Hospital of Jilin University), Ye Wu(Shanghai University)
Journal of the European Academy of Dermatology and Venereology
April 13, 2016
Cited by 10


Related Papers